Scientists guilty of 'hyping' benefits of gene research
By The Independent,
The Independent (UK)
| 09. 05. 2005
The leading fertility scientist Lord Winston has hit out at senior scientists, including two Nobel laureates, for making exaggerated claims about the supposed benefits of scientific research, warning they could trigger a public backlash.
Speaking on the eve of his presidential address to the annual meeting of the British Association for the Advancement of Science at Trinity College, Dublin, the former head of fertility medicine at the Hammersmith Hospital in London also criticised the "hype" over stem cells. He said stem cells are unlikely to be of much use for many years.
Lord Winston called on his colleagues to use more moderate language when describing scientific breakthroughs, singling out in his speech senior scientists and naming two Nobel laureates for making dangerously arrogant remarks.
"James Watson's assertion about the value of tampering with the human germ-line are a pretty good example," he said. Professor Watson, who won a Nobel prize for discovering the DNA double helix with Francis Crick, has extolled the possibility of altering the genes of germ-line sperm or egg cells to eradicate inherited diseases.
Lord Winston also...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...